NEOG Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$13.00median target· current $12.04 (+8.0%)4 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 16.00
EPS (TTM)$-0.04-85.6% YoY
Profit margin-0.9%HEALTHCARE
Market cap$2.63BMid cap
Valuation
- Forward P/E
- 16.00
- PEG ratio
- 0.66
- P/B
- 1.25
- P/S (TTM)
- 3.02
- EV/EBITDA
- 18.97
Profitability & growth
- ROE (TTM)
- -0.4%
- Operating margin
- 1.4%
- Revenue growth YoY
- -0.1%
- Dividend yield
- —
- Beta
- 1.79
Last earnings
Jul 30, 2026 · Estimate $0.03 · Reported $0.08
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Neogen Corporation
Company profileNeogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 620 LESHER PLACE, LANSING, MI
- Fiscal year end
- May
- Latest quarter
- May 31, 2026
Market cap$2.63B
Shares outstanding$218.1M
52W high$12.15
52W low$4.63
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent